Document:

Exhibit
10.8

 

DEBT
PURCHASE AGREEMENT

  

THIS
DEBT PURCHASE AGREEMENT (this “Agreement”), is made and entered into as of the 15th day of
February, 2017 (the “Effective Date”), by and among TCA GLOBAL CREDIT MASTER FUND, LP, a Cayman
Islands limited partnership, with an address of 3960 Howard Hughes Parkway, Suite 500, Las Vegas, NV 89169 (“Assignor”
or “Lender”), L2 CAPITAL, LLC (“Assignee”), and GROW SOLUTIONS HOLDINGS,
INC., a Nevada corporation (the “Borrower”).

 

WITNESSETH

 

WHEREAS,
the Borrower, Lender, and others entered into, or are otherwise parties to and bound by, the terms of a Senior Secured Credit
Facility Agreement dated as of June 30, 2015 but made effective as of December 7, 2015 (such Credit Agreement, together with any
amendments, renewals, substitutions, replacements or modifications from time to time, collectively referred to as the “Credit
Agreement”); and

 

WHEREAS,
pursuant to the Credit Agreement, the Borrower executed and delivered to Lender that certain Convertible Promissory Note dated
as of June 30, 2015, but made effective as of December 7, 2015, evidencing an aggregate amount of Loans under the Credit Agreement
in the amount of Nine Hundred Fifty Thousand Dollars ($950,000) (the “Original Note”); and

 

WHEREAS,
Assignee desires to purchase from Lender, and Lender is amenable to selling and assigning to Assignee, Assignor’s right,
title and interest in and to the monetary obligations evidenced by the Original Note, or portions thereof (or any replacement
notes issued in replacement thereof as hereby contemplated, as applicable) (the “Assigned Debt”), which
Assigned Debt shall be purchased by Assignee in multiple tranches as more specifically hereinafter set forth; and

 

WHEREAS,
on or prior to each “Purchase Tranche Closing” (as hereinafter defined), as directed by Lender, the Borrower agrees
to sever, split, divide and apportion the Original Note (or any replacement notes issued in replacement thereof as hereby contemplated,
as applicable) into two separate and distinct replacement notes, each in substantially the form as set forth on Exhibit
“A” attached hereto (the “Note Form”), one for the amount of the portion of the
Assigned Debt being sold and assigned at such Purchase Tranche Closing (the portion of the Assigned Debt being sold and assigned
at each separate Purchase Tranche Closing, as applicable, being referred to as the “Applicable Assigned Debt”),
and one for the remaining amount of the overall debt evidenced by the Credit Agreement and the Original Note (or any replacement
notes issued in replacement thereof as hereby contemplated, as applicable) (after the initial Purchase Tranche Closing, and receipt
of the Applicable Purchase Price for such initial Purchase Tranche by Lender, and assignment of such Applicable Assigned Debt
to Holder as hereby contemplated, such Applicable Assigned Debt, as then owned and held by Assignee, shall be evidenced by that
certain senior replacement convertible promissory note in the principal amount of $1,201,441.25 (as of February 14, 2017) issued
by Borrower to Assignee on the Effective Date (the “Assignee Replacement Note”);

 

NOW,
THEREFORE, in consideration of the mutual covenants hereinafter set forth, and other good and valuable consideration, the receipt
and sufficiency of which are hereby acknowledged and agreed, Assignor, Assignee, and Borrower hereby covenant and agree as follows:

 

1.             Recitals.
The recitations set forth in the preamble of this Agreement are true and correct and incorporated herein by this reference.

 

    

     

    

 

2.             Agreement to Assign Assigned Debt.

 

(a)       Purchase
Tranche Closings. Provided there is no default or breach under this Agreement, and that no event has occurred that, with the
passage of time, the giving of notice, or both, would constitute a default or breach under this Agreement, and subject to all
the terms and provisions of this Agreement, the Assignor hereby agrees to sell and assign to Assignee, and Assignee hereby agrees
to purchase from Assignor, the Assigned Debt, which Assigned Debt shall be sold in multiple separate tranches (each of such tranches
hereinafter referred to as a “Purchase Tranche”), each of such separate Purchase Tranches to be sold
and assigned on the respective dates and for the respective amounts set forth in the schedule attached hereto as Exhibit
“B” (each closing of a Purchase Tranche referred to as a “Purchase Tranche Closing”
and the purchase price to be paid for each Applicable Assigned Debt at each Purchase Tranche Closing, as shown on such attached
schedule, referred to as the “Applicable Purchase Price”); provided, however, nothing herein shall prevent
Assignee from electing to purchase a greater portion of the Assigned Debt, or more frequently, than that set forth in the attached
schedule for any given Purchase Tranche Closing, up to the aggregate amount of the Assigned Debt, by written notice to Assignor
delivered prior to the applicable Purchase Tranche Closing.

 

(b)       Deliveries
at Each Purchase Tranche Closing. Subject to the terms of this Agreement, at each Purchase Tranche Closing: (i) Lender shall
execute and deliver to Assignee, an assignment of the Applicable Assigned Debt being sold and assigned at such Purchase Tranche
Closing, substantially in the form attached hereto as Exhibit “C” (each, an “Assignment”);
(ii) Lender shall deliver to Assignee the original replacement note for the Applicable Assigned Debt being sold and assigned at
such Purchase Tranche Closing (subject to receipt of same by Lender from Borrower as provided in Section 2(c) below); and
(iii) Assignee shall pay to Lender the Applicable Purchase Price for the Applicable Assigned Debt being sold and assigned at such
Purchase Tranche Closing, by wire transfer of good and cleared U.S. currency to an account designated by Lender.

 

(c)       Borrower’s
Obligation to Sever Notes. On or prior to each Purchase Tranche Closing, and within no later than two (2) business days after
request therefor is made by Lender to Borrower, the Borrower agrees to sever, split, divide and apportion the Original Note (or
any replacement notes issued in replacement thereof as hereby contemplated, as applicable) into two separate and distinct and
newly issued replacement notes, each substantially in the Note Form. One of such replacement notes shall be for a principal amount
equal to the Applicable Purchase Price corresponding to the Applicable Assigned Debt for the applicable Purchase Tranche Closing,
and the other replacement note shall be for a principal amount equal to the remaining amount of the overall debt then existing
and evidenced by the Credit Agreement and the Original Note (or any replacement notes issued in replacement thereof as hereby
contemplated, as applicable). In order to clarify the foregoing, as an example, on or prior to the first Purchase Tranche Closing
contemplated hereby, upon request by Lender, the Borrower shall provide to Lender two replacement notes in replacement of the
Original Note, one for $325,000, which is the Applicable Purchase Price for the Applicable Assigned Debt being sold and assigned
at the first Purchase Tranche Closing, and the second for $876,441.25 (as of February 14, 2017), which is the amount of the overall
debt evidenced by the Credit Agreement and the Original Note, less the Applicable Purchase Price for the replacement note being
sold and assigned at the first Purchase Tranche Closing. This second replacement note shall then be severed in the same manner
for the second Purchase Tranche Closing, and this foregoing process of severing and issuing replacement notes shall be repeated
for each Purchase Tranche Closing, until the Assigned Debt is sold and assigned in full, or this Agreement is otherwise earlier
terminated in accordance with its terms. Assignee acknowledges and understands that Lender’s obligation to sell, assign
and deliver each original replacement note representing the Applicable Assigned Debt at each Purchase Tranche Closing is subject
to and conditioned upon Borrower executing and delivering such replacement notes to Lender in accordance with this Agreement.

 

    	 	2	 

     

    

 

(d)       Remaining
Debt. Assignee and Borrower acknowledge that at each Purchase Tranche Closing, and subject to Lender’s receipt of the
Applicable Purchase Price, only the Applicable Assigned Debt represented by the specific replacement note representing the applicable
Purchase Tranche shall be deemed sold and assigned hereunder, it being acknowledged by Assignee and by Borrower that the remaining
portion of the debt evidenced by the Credit Agreement and the Original Note (or any replacement notes issued in replacement thereof
as hereby contemplated, as applicable) for which the Applicable Purchase Price has not been paid and received by Lender (collectively,
the “Remaining Debt”) shall not be sold or assigned thereby unless and until additional replacement
notes for additional Purchase Tranches are thereafter sold in accordance with this Agreement and the Applicable Purchase Price
therefor is received by Lender.

 

(e)       No
Security Rights. Assignee and Borrower each hereby agree and acknowledge that the sale, transfer and assignment of the Assigned
Debt, or any portion thereof, shall be a sale, transfer and assignment of the monetary obligations evidenced by such Assigned
Debt (or portion thereof) only, and shall not include, and such sale, transfer and assignment expressly excludes, the Remaining
Debt, as well as excluding any and all security rights, rights to any collateral, or any other security interests or rights of
Assignor of any nature or kind related to, arising under, or pursuant to, the Credit Agreement, any other “Loan Documents”
(as defined in the Credit Agreement) related thereto, or any other security agreements, UCC financing statements, or any other
documents or instruments relating to the obligations of the Borrower or any “Guarantors” (as defined in the Credit
Agreement) to Assignor (collectively, the “Security Rights”), it being agreed and acknowledged that
all Security Rights shall remain with Assignor, as security for any portion of the Assigned Debt not assigned at any Purchase
Tranche Closing, the Remaining Debt, or any other obligations of Borrower or any Guarantors to Assignor.

 

3.             Conditions to Additional Purchases.

 

(a)       Initial
Purchase. The initial Purchase Tranche contemplated hereunder shall be closed and funded simultaneous with the execution of
this Agreement by Lender, Assignee and Borrower.

 

(b)      Subsequent Purchases.If the first Purchase Tranche Closing is consummated hereunder, and the Applicable Purchase Price
therefor is paid and received by Lender as contemplated under this Agreement, then Assignee’s obligation to purchase any
additional Purchase Tranches as hereby contemplated is a binding and continuing obligation of Assignee; provided, however, Assignee
shall have the right to terminate such obligation at any time during the term of this Agreement upon the occurrence of any of
the following events (each a “Trigger Event”): (i) the Borrower fails to stay current in its filing
obligations with the SEC; (ii) trading of the Borrower’s Common Stock on the “Principal Trading Market” (as
defined in the Credit Agreement) is stopped or halted for any reason; (iii) any suspension of electronic trading or settlement
services by the Depository Trust Company (“DTC”) with respect to the Common Stock occurs and is continuing,
or any receipt by the Borrower of any notice from DTC to the effect that a suspension of electronic trading or settlement services
by DTC with respect to the Common Stock is being imposed or is contemplated (unless, prior to such suspension, DTC shall have
notified the Borrower in writing that DTC has determined not to impose any such suspension); (iv) the Borrower’s transfer
agent (the “Transfer Agent”) fails to issue to Assignee any shares of the Borrower’s Common Stock
which may be due to Assignee in connection with any conversion rights exercised by Assignee under any promissory notes purchased
by Assignee hereunder, or notes issued in replacement thereof; (v) the Borrower fails to maintain its active status with its State
of organization; (vi) Borrower shall default (beyond any applicable notice and cure periods) in any of their obligations to Assignee
under the promissory notes purchased by Assignee hereunder, or notes issued in replacement thereof, or any other obligations of
Borrower to Assignee; or (vii) the Borrower fails to maintain any share reserve required by Assignee. Upon the occurrence of a
Trigger Event, in the event Assignee desires to terminate its obligation to purchase Purchase Tranches as hereby contemplated,
Assignee shall deliver to Lender written notice of such termination delivered within five (5) days of the date the Assignee becomes
aware of the occurrence of the Trigger Event (which notice shall include a statement of the Trigger Event that has occurred and
reasonable evidence of the occurrence thereof), whereupon Assignee’s obligation to purchase any additional Purchase Tranches
thereafter shall immediately terminate and be of no further force or effect.

 

    	 	3	 

     

    

 

4.             Representations
and Warranties of Assignor. Assignor makes the following representations and warranties to Assignee, each of which shall be
deemed made as of the Effective Date, and re-made as of each Purchase Tranche Closing:

 

(a)       Assignor
is the legal and equitable owner of Assignor’s right, title and interest in and to the Assigned Debt (or applicable portion
thereof being sold and assigned at each Purchase Tranche Closing), except for any portion of the Assigned Debt previously sold
and assigned to Assignee pursuant to this Agreement; and

 

(b)       Assignor
has not sold, transferred, assigned, pledged, hypothecated, or otherwise encumbered the Assigned Debt (or applicable portion thereof
being sold and assigned at each Purchase Tranche Closing), except for any portion of the Assigned Debt previously sold and assigned
to Assignee pursuant to this Agreement; and

 

(c)       The
Assignor is an entity duly organized, validly existing and in good standing under the laws of the jurisdiction of its organization
with full right, corporate, partnership or other applicable power and authority to enter into and to consummate the transactions
contemplated by this Agreement and otherwise to carry out its obligations hereunder, and the execution, delivery and performance
by the Assignor of the transactions contemplated by this Agreement have been duly authorized by all necessary corporate, partnership,
or similar action on the part of the Assignor; and

 

(d)       Except
for the foregoing representations and warranties, this Agreement and the Assignment is made by Assignor without recourse, representation
or warranty of any nature or kind, express or implied, and Assignor specifically disclaims any warranty, guaranty or representation,
oral or written, past, present or future with respect to the Assigned Debt, any portion thereof, or any instruments evidencing
same, including, without limitation: (i) the validity, effectiveness or enforceability of the Assigned Debt, any portion thereof,
or any instruments evidencing same; (ii) the validity, existence, or priority of any lien or security interest securing the obligations
of Borrower or any other Credit Parties evidenced by the Assigned Debt, any portion thereof, or any instruments evidencing same;
(iii) the existence of, or basis for, any claim, counterclaim, defense or offset relating to the Assigned Debt, any portion thereof,
or any instruments evidencing same; (iv) the financial condition of the Borrower, or any other Credit Parties or guarantor or
obligor liable under the Assigned Debt, any portion thereof, or any instruments evidencing same, or the ability of any such parties
to pay or perform their respective obligations under the Assigned Debt, any portion thereof, or any instruments evidencing same;
(v) the compliance of the Assigned Debt, any portion thereof, or any instruments evidencing same with any laws, ordinances or
regulations of any governmental agency or other body; (vi) the value or condition of any collateral securing the obligations under
the Assigned Debt, any portion thereof, or any instruments evidencing same; and (vii) the future performance of the Borrower or
any other Credit Parties or guarantor or obligor liable under the Assigned Debt, any portion thereof, or any instruments evidencing
same. Assignee acknowledges and represents to Assignor that Assignee has been given the opportunity to undertake its own investigations
of the Borrower, the Assigned Debt, any portion thereof, or any instruments evidencing same, and having undertaken and performed
all such investigations as Assignee deemed necessary or desirable, Assignee represents, warrants and agrees that it is relying
solely on its own investigation of the Borrower, the Assigned Debt, any portion thereof, or any instruments evidencing same, and
not any information whatsoever provided or to be provided by Assignor, or any representation or warranty of Assignor. This Agreement,
and each Assignment of the Assigned Debt, or portion thereof, as provided for herein is made on an “AS IS,”
“WHERE IS” basis, with all faults, and Assignee, by acceptance of this Agreement and each Assignment,
shall be deemed to have agreed and acknowledged that Assignor has fully performed, discharged and complied with all of Assignor’s
obligations, representations, warranties, covenants and agreements hereunder, that Assignor is discharged therefrom, and that
Assignor shall have no further liability with respect thereto, except only for those express warranties contained in this Agreement,
and Assignee, by such acceptance, expressly acknowledges that ASSIGNOR MAKES NO WARRANTY OR REPRESENTATIONS, EXPRESS OR IMPLIED,
OR ARISING BY OPERATION OF LAW, RELATING TO THE ASSIGNED DEBT, ANY PORTION THEREOF, OR ANY INSTRUMENTS EVIDENCING SAME, EXCEPT
AS SPECIFICALLY SET FORTH HEREIN.

 

    	 	4	 

     

    

 

(e)       The
Assignor is not now, and has not been during the preceding 90 days, an officer, director, 10% or more shareholder of the Borrower,
or in any other way an “affiliate” of Borrower, as that term is defined in Rule 144(a)(1) adopted pursuant to the
Securities Act of 1933, as amended.

 

5.             Representations
and Warranties of Assignee. Assignee makes the following representations and warranties to Assignor, each of which shall be
deemed made as of the Effective Date, and re-made as of each Purchase Tranche Closing:

 

(a)       The
Assignee is a legally recognized entity duly organized, validly existing and in good standing under the laws of the jurisdiction
of its organization with full right, corporate, partnership or other applicable power and authority to enter into and to consummate
the transactions contemplated by this Agreement and otherwise to carry out its obligations hereunder, and the execution, delivery
and performance by the Assignee of the transactions contemplated by this Agreement have been duly authorized by all necessary
corporate or similar action on the part of the Assignee.

 

(b)       This
Agreement, when executed and delivered by the Assignee, will constitute a valid and legally binding obligation of the Assignee,
enforceable against the Assignee in accordance with its terms, except: (i) as limited by applicable bankruptcy, insolvency, reorganization,
moratorium, fraudulent conveyance, and any other laws of general application affecting enforcement of creditors' rights generally;
or (ii) as limited by laws relating to the availability of specific performance, injunctive relief, or other equitable remedies.

 

(c)       The
Assignee: (i) either alone or together with its representatives, has such knowledge and experience in financial and business matters
as to be capable of evaluating the merits and risks of this investment and make an informed decision to so invest, and has so
evaluated the risks and merits of such investment; (ii) has the ability to bear the economic risks of this investment and can
afford a complete loss of such investment; (iii) understands the terms of and risks associated with the acquisition of the Assigned
Debt, or any portion thereof, or any instruments evidencing same, including, without limitation, a lack of liquidity, price transparency
or pricing availability and risks associated with the industry in which the Borrower operates; (iv) has had the opportunity to
review the Borrower, its business, its financial condition, its prospects, the Credit Agreement, the Assigned Debt, any portion
thereof, or any instruments evidencing same, all as the Assignee has determined to be necessary in connection with this Agreement
and the assignments contemplated hereby.

 

(d)       The
Assignee understands that: (i) the Assigned Debt, any portion thereof, or any instruments evidencing same, have not been registered
under the Securities Act of 1933 (the “Securities Act”) or the securities laws of any state; (ii) the
Assigned Debt, any portion thereof, or any instruments evidencing same, and any securities issuable upon conversion of the Assigned
Debt, or any portion thereof, is and will be “restricted securities” as said term is defined in Rule 144 of the Rules
and Regulations promulgated under the Securities Act (“Rule 144”); (iii) the Assigned Debt, any portion
thereof, or any instruments evidencing same, may not be sold, pledged or otherwise transferred unless a registration statement
for such transaction is effective under the Securities Act and any applicable state securities laws, or unless an exemption from
such registration is available with respect to such transaction; and (iv) the Assigned Debt, any portion thereof, or any instruments
evidencing same, will contain restrictive legends as to the foregoing in customary form.

 

    	 	5	 

     

    

 

(e)       The
Assignee is not accepting this Agreement or any Assignment as a result of any advertisement, article, notice or other communication
regarding the Assigned Debt, any portion thereof, or any instruments evidencing same published in any newspaper, magazine, internet
or social media, broadcast over television or radio, presented at any seminary, or under any other media generally circulated
or available to the public or any other general solicitation or general advertisement.

 

(f)       To
the knowledge of its officers, members and managers, neither the execution and delivery of this Agreement, or any Assignment,
nor the consummation of the transactions contemplated hereby, does or will violate any constitution, statute, regulation, rule,
injunction, judgment, order, decree, ruling, charge or other restriction of any government, governmental agency, or court to which
the Assignee is subject or any provision of its organizational documents or other similar governing instruments, or conflict with,
violate or constitute a default under any agreement, credit facility, debt or other instrument or understanding to which the Assignee
is a party. The Assignee has consulted such legal, tax and investment advisors as it, in its sole discretion, has deemed necessary
or appropriate in connection with this Agreement and the assignment of the Assigned Debt, any portion thereof, or any instruments
evidencing same as contemplated hereby.

 

(g)       To
the knowledge of its officers, members and managers, there is no action, suit, proceeding, judgment, claim or investigation pending,
or to the knowledge of the Assignee, threatened against the Assignee which could reasonably be expected in any manner to challenge
or seek to prevent, enjoin, alter or materially delay any of the transactions contemplated hereby.

 

(h)       To
the knowledge of its officers, members and managers, no authorization, consent, approval or other order of, or declaration to
or filing with, any governmental agency or body or other Person is required for the valid authorization, execution, delivery and
performance by the Assignee of this Agreement and the consummation of the transactions contemplated hereby.

 

(i)       The
Assignee hereby acknowledges that the Assigned Debt, any portion thereof, or any instruments evidencing same may only be disposed
of in compliance with state and federal securities laws. The Assignee further acknowledges that in connection with any transfer
of the Assigned Debt, any portion thereof, or any instruments evidencing same subsequent to the date hereof and other than pursuant
to an effective registration statement, or an applicable exemption to such registration requirements, the Borrower and/or the
Borrower’s transfer agent may require an opinion of counsel, the form and substance of which opinion shall be reasonably
satisfactory to the Borrower and/or the Borrower’s transfer agent, as applicable.

 

6.             Borrower
Acknowledgments. Borrower hereby represents and warrants that the obligations evidenced by the Credit Agreement and the Original
Note, including, without limitation, all obligations for the Assigned Debt and the Remaining Debt, are valid and enforceable obligations
of the Borrower subject to no defenses, setoffs, counterclaims, cross-actions or equities in favor of the Borrower, and to the
extent the Borrower has any defenses, setoffs, counterclaims, cross-actions or equities against Assignor and/or against the enforceability
of any such obligations, the Borrower acknowledges and agrees that same are hereby fully and unconditionally waived by the Borrower.
The Borrower further acknowledges its obligations under Section 2(c) above, and agrees to timely and promptly deliver replacement
notes to Lender as required by this Agreement. The Borrower further acknowledges that the Assigned Debt may only represent a portion
of the obligations due or owing under the Credit Agreement and the Original Note, and that the Assigned Debt is only being assigned
hereunder in Purchase Tranches as contemplated above. In that regard, the Borrower further acknowledges that the Remaining Debt,
and any portion of the Assigned Debt for which the Applicable Purchase Price therefor has not been received by Lender, are and
remain valid and enforceable obligations of the Borrower. Borrower agrees and acknowledges that it is and shall remain liable
to pay the Remaining Debt, and any portion of the Assigned Debt for which the Applicable Purchase Price therefor has not been
received by Lender, as same becomes due in accordance with the terms of the Credit Agreement and the Original Note, or any replacement
notes issued in replacement thereof as hereby contemplated, and nothing contained herein shall be deemed or construed any waiver
or to otherwise excuse performance by Borrower under its obligations to Lender.

  

    	 	6	 

     

    

 

7.             Release.
AS A MATERIAL INDUCEMENT FOR LENDER TO AGREE TO ENTER INTO THIS AGREEMENT, BORROWER AND ASSIGNEE HEREBY RELEASE LENDER, together
with all OF ITS PARTNERS AND AFFILIATES, AND THE officers, MEMBERS, DIRECTORS, PARTNERS, employees, agents AND ATTORNEYS of each
of the foregoing, from all claims, causes of action and liabilities OF ANY NATURE OR KIND IN ANY WAY relating, directly or indirectly,
to the ASSIGNED DEBT, ANY collateral securing ANY OBLIGATIONS THEREUNDER, thIS
AGREEMENT, OR ANY OTHER DEBTS OR OBLIGATIONS IN ANY WAY RELATING TO THE CREDIT AGREEMENT, TO THE EXTENT arising on or prior to
the date hereof, including, without limitation, any and all claims arising from or relating to negotiations, demands, requests
or exercise of remedies in connection with the ASSIGNED DEBT, thIS AGREEMENT, ANY
OTHER DEBTS OR OBLIGATIONS IN ANY WAY RELATING TO THE CREDIT AGREEMENT, and Any and All FEES OR CHARGES collected in connection
with the ASSIGNED DEBT, thIS AGREEMENT, OR ANY OTHER DEBTS OR OBLIGATIONS IN ANY
WAY RELATING TO THE CREDIT AGREEMENT. MOREOVER UPON DELIVERY OF EACH ASSIGNMENT HEREUNDER, THE FOREGOING RELEASE SHALL BE DEEMED
AUTOMATICALLY RE-MADE AND EFFECTIVE FOR ALL claims, causes of action and liabilities OF ANY NATURE OR KIND COVERED HEREBY TO THE
EXTENT arising on or prior to the date OF SUCH ASSIGNMENT.

 

8.            Default and Termination.

 

(a)       Breach
By Assignor. In the event Assignor shall breach any of its covenants or agreements hereunder, and such breach is not cured
within twenty (20) days after Assignor’s receipt of written notice of such breach from Assignee, which notice shall specify
the breach with specificity, then Assignee’s sole and exclusive remedy hereunder shall be to terminate this Agreement upon
written notice to Assignor, whereupon this Agreement shall terminate and Assignor and Assignee shall have no further obligation,
each to the other, under this Agreement. Assignor and Assignee agree that the foregoing exclusive remedy will be adequate and
each of them agrees that Assignee shall not have any other remedies, at law or in equity, for any breach by Assignor not cured
within any applicable notice and cure period, other than termination of this Agreement as hereby provided.

 

(b)       Breach
By Assignee. In the event Assignee shall breach any of its covenants or agreements hereunder, and such breach is not cured
within twenty (20) days after Assignee’s receipt of written notice of such breach from Assignor, which notice shall specify
the breach with specificity, then Assignor’s sole and exclusive remedy hereunder shall be to terminate this Agreement upon
written notice to Assignee, whereupon this Agreement shall terminate and Assignor and Assignee shall have no further obligation,
each to the other, under this Agreement. Assignor and Assignee agree that the foregoing exclusive remedy will be adequate and
each of them agrees that Assignor shall not have any other remedies, at law or in equity, for any breach by Assignee not cured
within any applicable notice and cure period, other than termination of this Agreement as hereby provided. Notwithstanding the
foregoing to the contrary, the foregoing notice and cure period shall not be applicable with respect to Assignee’s failure
to pay the Purchase Price at the Purchase Tranche Closing, and any such failure shall be deemed an immediate breach hereunder,
entitling Assignor to avail itself of the exclusive termination remedy hereby provided immediately upon such failure to pay the
Purchase Price at the Purchase Tranche Closing.

 

    	 	7	 

     

    

 

(c)       Breach
by Borrower. Any breach by Borrower under this Agreement, which breach is not cured within ten (10) days after Borrower’s
receipt of written notice of such breach, which notice shall specify the breach with specificity, shall be deemed an event of
default by Borrower under the Credit Agreement, and any such breach may be enforced by Assignor through any remedies available
to Assignor, at law or in equity, or under the Credit Agreement. Borrower shall have no rights to enforce this Agreement as against
Assignor or Assignee, nor shall any breach or default by Assignor or Assignee hereunder in any way abrogate, limit, or otherwise
affect Borrower’s obligations under the Credit Agreement and related Loan Documents.

 

9.            
No Waiver. The parties recognize and acknowledge that by entering into this Agreement, the Lender is not waiving any rights
or remedies it may have under any of the Loan Documents, any defaults or Events of Default arising thereunder, or any judgments
previously obtained by Lender in connection therewith. In addition, notwithstanding anything contained in this Agreement to the
contrary, the Lender shall have the right, at any time, to: (i) accept payments (whether in full or partial payments) of the then
outstanding Remaining Debt, or any portion of the Assigned Debt not assigned at any Purchase Tranche Closing, whether such payments
are made by the Borrower, or any other Person (whether in connection with such other Person’s purchase of all or any portion
of the then outstanding Remaining Debt, or any portion of the Assigned Debt not assigned at any Purchase Tranche Closing, or otherwise);
or (ii) enter into agreements with Borrower or any other Person for payments to be made to Lender by Borrower or any other Person
at such later dates and under such terms and conditions as Lender may elect in its sole and absolute discretion, and in any of
such events, or for any other reason whatsoever, in Lender’s sole and absolute discretion, Lender shall have the absolute
right to terminate this Agreement upon written notice to Assignee, without liability to Assignee or any other Person, with respect
to any portion of the Assigned Debt not yet sold and assigned to Assignee as of such date.

 

10.           Governing Law. This Agreement shall be governed by and construed in accordance with the laws governing the Credit Agreement.

 

11.           Successors and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties hereto and their respective
successors and assigns.

 

12.           Headings. The headings of the paragraphs of this Agreement have been included only for convenience, and shall not be deemed
in any manner to modify or limit any of the provisions of this Agreement or used in any manner in the interpretation of this Agreement.

 

13.           Interpretation. Whenever the context so requires in this Agreement, all words used in the singular shall be construed to
have been used in the plural (and vice versa), each gender shall be construed to include any other genders, and the word “Person”
shall be construed to include a natural person, a corporation, a firm, a partnership, a joint venture, a trust, an estate or any
other entity.

 

14.           Partial Invalidity. Each provision of this Agreement shall be valid and enforceable to the fullest extent permitted by
law. If any provision of this Agreement or the application of such provision to any person or circumstances shall, to any extent,
be invalid or unenforceable, then the remainder of this Agreement, or the application of such provision to persons or circumstances
other than those as to which it is held invalid or unenforceable, shall not be affected by such invalidity or unenforceability.

  

    	 	8	 

     

    

 

15.           Execution. This Agreement may be executed in one or more counterparts, all of which taken together shall be deemed and
considered one and the same Agreement. In the event that any signature is delivered by facsimile transmission or by e-mail delivery
of a “.pdf” format file or other similar format file, such signature shall be deemed an original for all purposes
and shall create a valid and binding obligation of the party executing same with the same force and effect as if such facsimile
or “.pdf” signature page was an original thereof.

 

16.           Effective Date. For purposes of this Agreement, the “Effective Date” shall mean the date when
this Agreement becomes fully executed by all parties hereto.

 

17.           Exclusive Agreement. Assignee hereby agrees that, unless and until the Assigned Debt is fully assigned hereunder, and the
Applicable Purchase Price for the entire Assigned Debt has been paid in full to Lender, then Assignee shall not engage or enter
into any other agreements to purchase or exchange any other debts or obligations of the Borrower, other than the Assigned Debt
owned by Lender.

 

[Signatures
on the following page]

 

    	 	9	 

     

    

 

IN
WITNESS WHEREOF, Assignor, Assignee, and Borrower have executed this Agreement as of the date above first written.

 

	 	Assignor:
	 	 	
	 	TCA
    GLOBAL CREDIT MASTER FUND, LP
	 	 	 
	 	By:	TCA
    Global Credit Fund GP, Ltd.
	 	Its:	General
    Partner
	 	 	
	 	By:	
	 	 	Robert
    Press, Director
	 	 	
	 	Date:	
	 	 	 
	 	Assignee:
	 	 
	 	L2 CAPITAL, LLC
	 	 	
	 	By:	
	 	Name:	
	 	Title:	
	 	 	
	 	Date:	

 

    	 	10	 

     

    

 

IN
WITNESS WHEREOF, Assignor, Assignee, and Borrower have executed this Agreement as of the date above first written.

 

	Borrower:	 
	 	 
	GROW
    SOLUTIONS HOLDINGS, INC.,	 
	a
    Nevada corporation	 
	 	 
	By:	 	 
	Name:	 	 
	Title:	 	 
	Date:	 	 

  

    	 	11	 

     

    

 

EXHIBIT
“A”

 

FORM
NOTE

 

    	 	12	 

     

    

 

EXHIBIT
“B”

 

PURCHASE
TRANCHES

 

	Purchase
    Tranche

 Number	Amount
    of Principal Assigned	Applicable
    Purchase Price	Date
    for Purchase Tranche Closing
	1	$325,000	$325,000	Simultaneously
    with execution of this Agreement
	All
    additional Purchase Tranches until Assignee has purchased the entire amount of the Assigned Debt	$300,000	$300,000	Each
    Friday after the five week anniversary of the immediately preceding  Purchase Tranche Closing

 

    	 	13	 

     

    

 

EXHIBIT
“C”

 

FORM
OF ASSIGNMENT

 

 

14Exhibit 10.9

 

SECURITIES PURCHASE AGREEMENT

 

This SECURITIES PURCHASE
AGREEMENT (the “Agreement”), dated as of January 19, 2017, by and between GROW SOLUTIONS HOLDINGS, INC.,
a Nevada corporation, with headquarters located at 1111 Broadway - Suite 406, Denver, CO 80203 (the “Company”), and
POWER UP LENDING GROUP LTD., a Virginia corporation, with its address at 111 Great Neck Road, Suite 216, Great Neck, NY
11021 (the “Buyer”).

 

WHEREAS:

 

A.       The
Company and the Buyer are executing and delivering this Agreement in reliance upon the exemption from securities registration afforded
by the rules and regulations as promulgated by the United States Securities and Exchange Commission (the “SEC”) under
the Securities Act of 1933, as amended (the “1933 Act”);

 

B.       Buyer
desires to purchase and the Company desires to issue and sell, upon the terms and conditions set forth in this Agreement an 8%
convertible note of the Company, in the form attached hereto as Exhibit A, in the aggregate principal amount of $125,000.00 (together
with any note(s) issued in replacement thereof or as a dividend thereon or otherwise with respect thereto in accordance with the
terms thereof, the “Note”), convertible into shares of common stock, $0.001 par value per share, of the Company (the
“Common Stock”), upon the terms and subject to the limitations and conditions set forth in such Note.

 

C.       The
Buyer wishes to purchase, upon the terms and conditions stated in this Agreement, such principal amount of Note as is set forth
immediately below its name on the signature pages hereto; and

 

NOW THEREFORE,
the Company and the Buyer severally (and not jointly) hereby agree as follows:

 

1.       Purchase
and Sale of Note.

 

a.       Purchase
of Note. On the Closing Date (as defined below), the Company shall issue and sell to the Buyer and the Buyer agrees to purchase
from the Company such principal amount of Note as is set forth immediately below the Buyer’s name on the signature pages
hereto.

 

     

     

    

 

b.       Form
of Payment. On the Closing Date (as defined below), (i) the Buyer shall pay the purchase price for the Note to be issued and
sold to it at the Closing (as defined below) (the “Purchase Price”) by wire transfer of immediately available funds
to the Company, in accordance with the Company’s written wiring instructions, against delivery of the Note in the principal
amount equal to the Purchase Price as is set forth immediately below the Buyer’s name on the signature pages hereto, and
(ii) the Company shall deliver such duly executed Note on behalf of the Company, to the Buyer, against delivery of such Purchase
Price.

 

c.       Closing
Date. Subject to the satisfaction (or written waiver) of the conditions thereto set forth in Section 6 and Section 7 below,
the date and time of the issuance and sale of the Note pursuant to this Agreement (the “Closing Date”) shall be 12:00
noon, Eastern Standard Time on or about January 20, 2017, or such other mutually agreed upon time. The closing of the transactions
contemplated by this Agreement (the “Closing”) shall occur on the Closing Date at such location as may be agreed to
by the parties.

 

2.       Buyer’s
Representations and Warranties. The Buyer represents and warrants to the Company that:

 

a.       Investment
Purpose. As of the date hereof, the Buyer is purchasing the Note and the shares of Common Stock issuable upon conversion of
or otherwise pursuant to the Note (including, without limitation, such additional shares of Common Stock, if any, as are issuable
(i) on account of interest on the Note, (ii) as a result of the events described in Sections 1.3 and 1.4(g) of the Note
or (iii) in payment of the Standard Liquidated Damages Amount (as defined in Section 2(f) below) pursuant to this Agreement,
such shares of Common Stock being collectively referred to herein as the “Conversion Shares” and, collectively with
the Note, the “Securities”) for its own account and not with a present view towards the public sale or distribution
thereof, except pursuant to sales registered or exempted from registration under the 1933 Act; provided, however,
that by making the representations herein, the Buyer does not agree to hold any of the Securities for any minimum or other specific
term and reserves the right to dispose of the Securities at any time in accordance with or pursuant to a registration statement
or an exemption under the 1933 Act.

 

b.       Accredited
Investor Status. The Buyer is an “accredited investor” as that term is defined in Rule 501(a) of Regulation D (an
“Accredited Investor”).

 

c.       Reliance
on Exemptions. The Buyer understands that the Securities are being offered and sold to it in reliance upon specific exemptions
from the registration requirements of United States federal and state securities laws and that the Company is relying upon the
truth and accuracy of, and the Buyer’s compliance with, the representations, warranties, agreements, acknowledgments and
understandings of the Buyer set forth herein in order to determine the availability of such exemptions and the eligibility of the
Buyer to acquire the Securities.

 

    	 	2	 

     

    

 

d.       Information.
The Buyer and its advisors, if any, have been, and for so long as the Note remain outstanding will continue to be, furnished with
all materials relating to the business, finances and operations of the Company and materials relating to the offer and sale of
the Securities which have been requested by the Buyer or its advisors. The Buyer and its advisors, if any, have been, and for so
long as the Note remain outstanding will continue to be, afforded the opportunity to ask questions of the Company. Notwithstanding
the foregoing, the Company has not disclosed to the Buyer any material nonpublic information and will not disclose such information
unless such information is disclosed to the public prior to or promptly following such disclosure to the Buyer. Neither such inquiries
nor any other due diligence investigation conducted by Buyer or any of its advisors or representatives shall modify, amend or affect
Buyer’s right to rely on the Company’s representations and warranties contained in Section 3 below. The Buyer understands
that its investment in the Securities involves a significant degree of risk. The Buyer is not aware of any facts that may constitute
a breach of any of the Company's representations and warranties made herein.

 

e.       Governmental
Review. The Buyer understands that no United States federal or state agency or any other government or governmental agency
has passed upon or made any recommendation or endorsement of the Securities.

 

f.       Transfer
or Re-sale. The Buyer understands that (i) the sale or re-sale of the Securities has not been and is not being registered under
the 1933 Act or any applicable state securities laws, and the Securities may not be transferred unless (a) the Securities
are sold pursuant to an effective registration statement under the 1933 Act, (b) the Buyer shall have delivered to the Company,
at the cost of the Buyer, an opinion of counsel that shall be in form, substance and scope customary for opinions of counsel in
comparable transactions to the effect that the Securities to be sold or transferred may be sold or transferred pursuant to an exemption
from such registration, which opinion shall be accepted by the Company, (c) the Securities are sold or transferred to an “affiliate”
(as defined in Rule 144 promulgated under the 1933 Act (or a successor rule) (“Rule 144”)) of the Buyer who agrees
to sell or otherwise transfer the Securities only in accordance with this Section 2(f) and who is an Accredited Investor, (d) the
Securities are sold pursuant to Rule 144, or (e) the Securities are sold pursuant to Regulation S under the 1933 Act (or a
successor rule) (“Regulation S”), and the Buyer shall have delivered to the Company, at the cost of the Buyer, an opinion
of counsel that shall be in form, substance and scope customary for opinions of counsel in corporate transactions, which opinion
shall be accepted by the Company; (ii) any sale of such Securities made in reliance on Rule 144 may be made only in accordance
with the terms of said Rule and further, if said Rule is not applicable, any re-sale of such Securities under circumstances in
which the seller (or the person through whom the sale is made) may be deemed to be an underwriter (as that term is defined in the
1933 Act) may require compliance with some other exemption under the 1933 Act or the rules and regulations of the SEC thereunder;
and (iii) neither the Company nor any other person is under any obligation to register such Securities under the 1933 Act or any
state securities laws or to comply with the terms and conditions of any exemption thereunder (in each case). Notwithstanding the
foregoing or anything else contained herein to the contrary, the Securities may be pledged as collateral in connection with a bona
fide margin account or other lending arrangement.

 

    	 	3	 

     

    

 

g.       Legends.
The Buyer understands that the Note and, until such time as the Conversion Shares have been registered under the 1933 Act may be
sold pursuant to Rule 144 or Regulation S without any restriction as to the number of securities as of a particular date that can
then be immediately sold, the Conversion Shares may bear a restrictive legend in substantially the following form (and a stop-transfer
order may be placed against transfer of the certificates for such Securities):

 

“NEITHER THE ISSUANCE AND SALE
OF THE SECURITIES REPRESENTED BY THIS CERTIFICATE NOR THE SECURITIES INTO WHICH THESE SECURITIES ARE EXERCISABLE HAVE BEEN REGISTERED
UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR APPLICABLE STATE SECURITIES LAWS. THE SECURITIES MAY NOT BE OFFERED FOR SALE,
SOLD, TRANSFERRED OR ASSIGNED (I) IN THE ABSENCE OF (A) AN EFFECTIVE REGISTRATION STATEMENT FOR THE SECURITIES UNDER THE SECURITIES
ACT OF 1933, AS AMENDED, OR (B) AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY THE HOLDER), IN A GENERALLY ACCEPTABLE
FORM, THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT OR (II) UNLESS SOLD PURSUANT TO RULE 144 OR RULE 144A UNDER SAID ACT. NOTWITHSTANDING
THE FOREGOING, THE SECURITIES MAY BE PLEDGED IN CONNECTION WITH A BONA FIDE MARGIN ACCOUNT OR OTHER LOAN OR FINANCING ARRANGEMENT
SECURED BY THE SECURITIES.”

 

The legend set forth
above shall be removed and the Company shall issue a certificate without such legend to the holder of any Security upon which it
is stamped, if, unless otherwise required by applicable state securities laws, (a) such Security is registered for sale under an
effective registration statement filed under the 1933 Act or otherwise may be sold pursuant to Rule 144 or Regulation S without
any restriction as to the number of securities as of a particular date that can then be immediately sold, or (b) such holder provides
the Company with an opinion of counsel, in form, substance and scope customary for opinions of counsel in comparable transactions,
to the effect that a public sale or transfer of such Security may be made without registration under the 1933 Act, which opinion
shall be accepted by the Company so that the sale or transfer is effected. The Buyer agrees to sell all Securities, including those
represented by a certificate(s) from which the legend has been removed, in compliance with applicable prospectus delivery requirements,
if any. In the event that the Company does not accept the opinion of counsel provided by the Buyer with respect to the transfer
of Securities pursuant to an exemption from registration, such as Rule 144 or Regulation S, at the Deadline, it will be considered
an Event of Default pursuant to Section 3.2 of the Note.

 

    	 	4	 

     

    

 

h.       Authorization;
Enforcement. This Agreement has been duly and validly authorized. This Agreement has been duly executed and delivered on behalf
of the Buyer, and this Agreement constitutes a valid and binding agreement of the Buyer enforceable in accordance with its terms.

 

i.       Residency.
The Buyer is a resident of the jurisdiction set forth immediately below the Buyer’s name on the signature pages hereto.

 

3.       Representations
and Warranties of the Company. The Company represents and warrants to the Buyer that:

 

a.       Organization
and Qualification. The Company and each of its Subsidiaries (as defined below), if any, is a corporation duly organized, validly
existing and in good standing under the laws of the jurisdiction in which it is incorporated, with full power and authority (corporate
and other) to own, lease, use and operate its properties and to carry on its business as and where now owned, leased, used, operated
and conducted. Schedule 3(a) sets forth a list of all of the Subsidiaries of the Company and the jurisdiction in which each is
incorporated. The Company and each of its Subsidiaries is duly qualified as a foreign corporation to do business and is in good
standing in every jurisdiction in which its ownership or use of property or the nature of the business conducted by it makes such
qualification necessary except where the failure to be so qualified or in good standing would not have a Material Adverse Effect.
“Material Adverse Effect” means any material adverse effect on the business, operations, assets, financial condition
or prospects of the Company or its Subsidiaries, if any, taken as a whole, or on the transactions contemplated hereby or by the
agreements or instruments to be entered into in connection herewith. “Subsidiaries” means any corporation or other
organization, whether incorporated or unincorporated, in which the Company owns, directly or indirectly, any equity or other ownership
interest.

 

b.       Authorization;
Enforcement. (i) The Company has all requisite corporate power and authority to enter into and perform this Agreement, the
Note and to consummate the transactions contemplated hereby and thereby and to issue the Securities, in accordance with the terms
hereof and thereof, (ii) the execution and delivery of this Agreement, the Note by the Company and the consummation by it of the
transactions contemplated hereby and thereby (including without limitation, the issuance of the Note and the issuance and reservation
for issuance of the Conversion Shares issuable upon conversion or exercise thereof) have been duly authorized by the Company’s
Board of Directors and no further consent or authorization of the Company, its Board of Directors, or its shareholders is required,
(iii) this Agreement has been duly executed and delivered by the Company by its authorized representative, and such authorized
representative is the true and official representative with authority to sign this Agreement and the other documents executed in
connection herewith and bind the Company accordingly, and (iv) this Agreement constitutes, and upon execution and delivery by the
Company of the Note, each of such instruments will constitute, a legal, valid and binding obligation of the Company enforceable
against the Company in accordance with its terms.

 

    	 	5	 

     

    

 

c.       Capitalization.
As of the date hereof, the authorized capital stock of the Company consists of: (i) 100,000,000 authorized shares of Common Stock,
$0.001 par value per share, of which 46716612 shares are issued and outstanding; and (ii) except as disclosed in the SEC Documents
(as defined below), 25,000,000 authorized shares of Preferred Stock of which no shares
are issued and outstanding; no shares are reserved for issuance pursuant to the Company’s stock option plans, no shares are
reserved for issuance pursuant to securities (other than the Note) exercisable for, or convertible into or exchangeable for shares
of Common Stock and 6,007,369 shares are reserved for issuance upon conversion of the Note. All of such outstanding shares of capital
stock are, or upon issuance will be, duly authorized, validly issued, fully paid and non-assessable. No shares of capital stock
of the Company are subject to preemptive rights or any other similar rights of the shareholders of the Company or any liens or
encumbrances imposed through the actions or failure to act of the Company. The Company has furnished to the Buyer true and correct
copies of the Company’s Certificate of Incorporation as in effect on the date hereof (“Certificate of Incorporation”),
the Company’s By-laws, as in effect on the date hereof (the “By-laws”), and the terms of all securities convertible
into or exercisable for Common Stock of the Company and the material rights of the holders thereof in respect thereto. The Company
shall provide the Buyer with a written update of this representation signed by the Company’s Chief Executive on behalf of
the Company as of the Closing Date.

 

d.       Issuance
of Shares. The Conversion Shares are duly authorized and reserved for issuance and, upon conversion of the Note in accordance
with its respective terms, will be validly issued, fully paid and non-assessable, and free from all taxes, liens, claims and encumbrances
with respect to the issue thereof and shall not be subject to preemptive rights or other similar rights of shareholders of the
Company and will not impose personal liability upon the holder thereof.

 

e.       Acknowledgment
of Dilution. The Company understands and acknowledges the potentially dilutive effect to the Common Stock upon the issuance
of the Conversion Shares upon conversion of the Note. The Company further acknowledges that its obligation to issue Conversion
Shares upon conversion of the Note in accordance with this Agreement, the Note is absolute and unconditional regardless of the
dilutive effect that such issuance may have on the ownership interests of other shareholders of the Company.

 

    	 	6	 

     

    

 

f.       No
Conflicts. The execution, delivery and performance of this Agreement, the Note by the Company and the consummation by the Company
of the transactions contemplated hereby and thereby (including, without limitation, the issuance and reservation for issuance of
the Conversion Shares) will not (i) conflict with or result in a violation of any provision of the Certificate of Incorporation
or By-laws, or (ii) violate or conflict with, or result in a breach of any provision of, or constitute a default (or an event which
with notice or lapse of time or both could become a default) under, or give to others any rights of termination, amendment, acceleration
or cancellation of, any agreement, indenture, patent, patent license or instrument to which the Company or any of its Subsidiaries
is a party, or (iii) result in a violation of any law, rule, regulation, order, judgment or decree (including federal and state
securities laws and regulations and regulations of any self-regulatory organizations to which the Company or its securities are
subject) applicable to the Company or any of its Subsidiaries or by which any property or asset of the Company or any of its Subsidiaries
is bound or affected (except for such conflicts, defaults, terminations, amendments, accelerations, cancellations and violations
as would not, individually or in the aggregate, have a Material Adverse Effect). Neither the Company nor any of its Subsidiaries
is in violation of its Certificate of Incorporation, By-laws or other organizational documents and neither the Company nor any
of its Subsidiaries is in default (and no event has occurred which with notice or lapse of time or both could put the Company or
any of its Subsidiaries in default) under, and neither the Company nor any of its Subsidiaries has taken any action or failed to
take any action that would give to others any rights of termination, amendment, acceleration or cancellation of, any agreement,
indenture or instrument to which the Company or any of its Subsidiaries is a party or by which any property or assets of the Company
or any of its Subsidiaries is bound or affected, except for possible defaults as would not, individually or in the aggregate, have
a Material Adverse Effect. The businesses of the Company and its Subsidiaries, if any, are not being conducted, and shall not be
conducted so long as the Buyer owns any of the Securities, in violation of any law, ordinance or regulation of any governmental
entity. Except as specifically contemplated by this Agreement and as required under the 1933 Act and any applicable state securities
laws, the Company is not required to obtain any consent, authorization or order of, or make any filing or registration with, any
court, governmental agency, regulatory agency, self regulatory organization or stock market or any third party in order for it
to execute, deliver or perform any of its obligations under this Agreement, the Note in accordance with the terms hereof or thereof
or to issue and sell the Note in accordance with the terms hereof and to issue the Conversion Shares upon conversion of the Note.
All consents, authorizations, orders, filings and registrations which the Company is required to obtain pursuant to the preceding
sentence have been obtained or effected on or prior to the date hereof. If the Company is listed on the OTCBB, the Company is not
in violation of the listing requirements of the Over-the-Counter Bulletin Board (the “OTCBB”) and does not reasonably
anticipate that the Common Stock will be delisted by the OTCBB in the foreseeable future. The Company and its Subsidiaries are
unaware of any facts or circumstances which might give rise to any of the foregoing.

 

    	 	7	 

     

    

 

g.       SEC
Documents; Financial Statements. The Company has filed all reports, schedules, forms, statements and other documents required
to be filed by it with the SEC pursuant to the reporting requirements of the Securities Exchange Act of 1934, as amended (the “1934
Act”) (all of the foregoing filed prior to the date hereof and all exhibits included therein and financial statements and
schedules thereto and documents (other than exhibits to such documents) incorporated by reference therein, being hereinafter referred
to herein as the “SEC Documents”). Upon written request the Company will deliver to the Buyer true and complete copies
of the SEC Documents, except for such exhibits and incorporated documents. As of their respective dates or if amended, as of the
dates of the amendments, the SEC Documents complied in all material respects with the requirements of the 1934 Act and the rules
and regulations of the SEC promulgated thereunder applicable to the SEC Documents, and none of the SEC Documents, at the time they
were filed with the SEC, contained any untrue statement of a material fact or omitted to state a material fact required to be stated
therein or necessary in order to make the statements therein, in light of the circumstances under which they were made, not misleading.
None of the statements made in any such SEC Documents is, or has been, required to be amended or updated under applicable law (except
for such statements as have been amended or updated in subsequent filings prior the date hereof). As of their respective dates
or if amended, as of the dates of the amendments, the financial statements of the Company included in the SEC Documents complied
as to form in all material respects with applicable accounting requirements and the published rules and regulations of the SEC
with respect thereto. Such financial statements have been prepared in accordance with United States generally accepted accounting
principles, consistently applied, during the periods involved and fairly present in all material respects the consolidated financial
position of the Company and its consolidated Subsidiaries as of the dates thereof and the consolidated results of their operations
and cash flows for the periods then ended (subject, in the case of unaudited statements, to normal year-end audit adjustments).
Except as set forth in the financial statements of the Company included in the SEC Documents, the Company has no liabilities, contingent
or otherwise, other than (i) liabilities incurred in the ordinary course of business subsequent to September 30, 2016, and (ii)
obligations under contracts and commitments incurred in the ordinary course of business and not required under generally accepted
accounting principles to be reflected in such financial statements, which, individually or in the aggregate, are not material to
the financial condition or operating results of the Company. The Company is subject to the reporting requirements of the 1934 Act.

 

h.       Absence
of Certain Changes. Since September 30, 2016, except as set forth in the SEC Documents, there has been no material adverse
change and no material adverse development in the assets, liabilities, business, properties, operations, financial condition, results
of operations, prospects or 1934 Act reporting status of the Company or any of its Subsidiaries.

 

i.       Absence
of Litigation. Except as set forth in the SEC Documents or public disclosures disseminated by the Company, there is no action,
suit, claim, proceeding, inquiry or investigation before or by any court, public board, government agency, self-regulatory organization
or body pending or, to the knowledge of the Company or any of its Subsidiaries, threatened against or affecting the Company or
any of its Subsidiaries, or their officers or directors in their capacity as such, that could have a Material Adverse Effect. The
Company and its Subsidiaries are unaware of any facts or circumstances which might give rise to any of the foregoing.

 

    	 	8	 

     

    

 

j.       Patents,
Copyrights, etc. The Company and each of its Subsidiaries owns or possesses the requisite licenses or rights to use all patents,
patent applications, patent rights, inventions, know-how, trade secrets, trademarks, trademark applications, service marks, service
names, trade names and copyrights (“Intellectual Property”) necessary to enable it to conduct its business as now operated
(and, as presently contemplated to be operated in the future); there is no claim or action by any person pertaining to, or proceeding
pending, or to the Company’s knowledge threatened, which challenges the right of the Company or of a Subsidiary with respect
to any Intellectual Property necessary to enable it to conduct its business as now operated (and, as presently contemplated to
be operated in the future); to the best of the Company’s knowledge, the Company’s or its Subsidiaries’ current
and intended products, services and processes do not infringe on any Intellectual Property or other rights held by any person;
and the Company is unaware of any facts or circumstances which might give rise to any of the foregoing. The Company and each of
its Subsidiaries have taken reasonable security measures to protect the secrecy, confidentiality and value of their Intellectual
Property.

 

k.       No
Materially Adverse Contracts, Etc. Neither the Company nor any of its Subsidiaries is subject to any charter, corporate or
other legal restriction, or any judgment, decree, order, rule or regulation which in the judgment of the Company’s officers
has or is expected in the future to have a Material Adverse Effect. Neither the Company nor any of its Subsidiaries is a party
to any contract or agreement which in the judgment of the Company’s officers has or is expected to have a Material Adverse
Effect.

 

l.       Tax
Status. The Company and each of its Subsidiaries has made or filed all federal, state and foreign income and all other tax
returns, reports and declarations required by any jurisdiction to which it is subject (unless and only to the extent that the Company
and each of its Subsidiaries has set aside on its books provisions reasonably adequate for the payment of all unpaid and unreported
taxes) and has paid all taxes and other governmental assessments and charges that are material in amount, shown or determined to
be due on such returns, reports and declarations, except those being contested in good faith and has set aside on its books provisions
reasonably adequate for the payment of all taxes for periods subsequent to the periods to which such returns, reports or declarations
apply. There are no unpaid taxes in any material amount claimed to be due by the taxing authority of any jurisdiction, and the
officers of the Company know of no basis for any such claim. The Company has not executed a waiver with respect to the statute
of limitations relating to the assessment or collection of any foreign, federal, state or local tax. None of the Company’s
tax returns is presently being audited by any taxing authority.

 

m.       Certain
Transactions. Except for arm’s length transactions pursuant to which the Company or any of its Subsidiaries makes payments
in the ordinary course of business upon terms no less favorable than the Company or any of its Subsidiaries could obtain from third
parties and other than the grant of stock options disclosed on Schedule 3(c), none of the officers, directors, or employees of
the Company is presently a party to any transaction with the Company or any of its Subsidiaries (other than for services as employees,
officers and directors), including any contract, agreement or other arrangement providing for the furnishing of services to or
by, providing for rental of real or personal property to or from, or otherwise requiring payments to or from any officer, director
or such employee or, to the knowledge of the Company, any corporation, partnership, trust or other entity in which any officer,
director, or any such employee has a substantial interest or is an officer, director, trustee or partner.

 

    	 	9	 

     

    

 

n.       Disclosure.
All information relating to or concerning the Company or any of its Subsidiaries set forth in this Agreement and provided to the
Buyer pursuant to Section 2(d) hereof and otherwise in connection with the transactions contemplated hereby is true and correct
in all material respects and the Company has not omitted to state any material fact necessary in order to make the statements made
herein or therein, in light of the circumstances under which they were made, not misleading. No event or circumstance has occurred
or exists with respect to the Company or any of its Subsidiaries or its or their business, properties, prospects, operations or
financial conditions, which, under applicable law, rule or regulation, requires public disclosure or announcement by the Company
but which has not been so publicly announced or disclosed (assuming for this purpose that the Company’s reports filed under
the 1934 Act are being incorporated into an effective registration statement filed by the Company under the 1933 Act).

 

o.       Acknowledgment
Regarding Buyer’ Purchase of Securities. The Company acknowledges and agrees that the Buyer is acting solely in the capacity
of arm’s length purchasers with respect to this Agreement and the transactions contemplated hereby. The Company further acknowledges
that the Buyer is not acting as a financial advisor or fiduciary of the Company (or in any similar capacity) with respect to this
Agreement and the transactions contemplated hereby and any statement made by the Buyer or any of its respective representatives
or agents in connection with this Agreement and the transactions contemplated hereby is not advice or a recommendation and is merely
incidental to the Buyer’ purchase of the Securities. The Company further represents to the Buyer that the Company’s
decision to enter into this Agreement has been based solely on the independent evaluation of the Company and its representatives.

 

p.       No
Integrated Offering. Neither the Company, nor any of its affiliates, nor any person acting on its or their behalf, has directly
or indirectly made any offers or sales in any security or solicited any offers to buy any security under circumstances that would
require registration under the 1933 Act of the issuance of the Securities to the Buyer. The issuance of the Securities to the Buyer
will not be integrated with any other issuance of the Company’s securities (past, current or future) for purposes of any
shareholder approval provisions applicable to the Company or its securities.

 

q.       No
Brokers. The Company has taken no action which would give rise to any claim by any person for brokerage commissions, transaction
fees or similar payments relating to this Agreement or the transactions contemplated hereby.

 

    	 	10	 

     

    

 

r.       Permits;
Compliance. The Company and each of its Subsidiaries is in possession of all franchises, grants, authorizations, licenses,
permits, easements, variances, exemptions, consents, certificates, approvals and orders necessary to own, lease and operate its
properties and to carry on its business as it is now being conducted (collectively, the “Company Permits”), and there
is no action pending or, to the knowledge of the Company, threatened regarding suspension or cancellation of any of the Company
Permits. Neither the Company nor any of its Subsidiaries is in conflict with, or in default or violation of, any of the Company
Permits, except for any such conflicts, defaults or violations which, individually or in the aggregate, would not reasonably be
expected to have a Material Adverse Effect. Since September 30, 2016, neither the Company nor any of its Subsidiaries has received
any notification with respect to possible conflicts, defaults or violations of applicable laws, except for notices relating to
possible conflicts, defaults or violations, which conflicts, defaults or violations would not have a Material Adverse Effect.

 

s.       Environmental
Matters.

 

(i)       There
are, to the Company’s knowledge, with respect to the Company or any of its Subsidiaries or any predecessor of the Company,
no past or present violations of Environmental Laws (as defined below), releases of any material into the environment, actions,
activities, circumstances, conditions, events, incidents, or contractual obligations which may give rise to any common law environmental
liability or any liability under the Comprehensive Environmental Response, Compensation and Liability Act of 1980 or similar federal,
state, local or foreign laws and neither the Company nor any of its Subsidiaries has received any notice with respect to any of
the foregoing, nor is any action pending or, to the Company’s knowledge, threatened in connection with any of the foregoing.
The term “Environmental Laws” means all federal, state, local or foreign laws relating to pollution or protection of
human health or the environment (including, without limitation, ambient air, surface water, groundwater, land surface or subsurface
strata), including, without limitation, laws relating to emissions, discharges, releases or threatened releases of chemicals, pollutants
contaminants, or toxic or hazardous substances or wastes (collectively, “Hazardous Materials”) into the environment,
or otherwise relating to the manufacture, processing, distribution, use, treatment, storage, disposal, transport or handling of
Hazardous Materials, as well as all authorizations, codes, decrees, demands or demand letters, injunctions, judgments, licenses,
notices or notice letters, orders, permits, plans or regulations issued, entered, promulgated or approved thereunder.

 

(ii)       Other
than those that are or were stored, used or disposed of in compliance with applicable law, no Hazardous Materials are contained
on or about any real property currently owned, leased or used by the Company or any of its Subsidiaries, and no Hazardous Materials
were released on or about any real property previously owned, leased or used by the Company or any of its Subsidiaries during
the period the property was owned, leased or used by the Company or any of its Subsidiaries, except in the normal course of the
Company’s or any of its Subsidiaries’ business.

 

    	 	11	 

     

    

 

(iii)       There
are no underground storage tanks on or under any real property owned, leased or used by the Company or any of its Subsidiaries
that are not in compliance with applicable law.

 

t.       Title
to Property. The Company and its Subsidiaries have good and marketable title in fee simple to all real property and good and
marketable title to all personal property owned by them which is material to the business of the Company and its Subsidiaries,
in each case free and clear of all liens, encumbrances and defects except such as are described in Schedule 3(t) or such as would
not have a Material Adverse Effect. Any real property and facilities held under lease by the Company and its Subsidiaries are held
by them under valid, subsisting and enforceable leases with such exceptions as would not have a Material Adverse Effect.

 

u.       Insurance.
The Company and each of its Subsidiaries are insured by insurers of recognized financial responsibility against such losses and
risks and in such amounts as management of the Company believes to be prudent and customary in the businesses in which the Company
and its Subsidiaries are engaged. Neither the Company nor any such Subsidiary has any reason to believe that it will not be able
to renew its existing insurance coverage as and when such coverage expires or to obtain similar coverage from similar insurers
as may be necessary to continue its business at a cost that would not have a Material Adverse Effect. Upon written request the
Company will provide to the Buyer true and correct copies of all policies relating to directors’ and officers’ liability
coverage, errors and omissions coverage, and commercial general liability coverage.

 

v.       Internal
Accounting Controls. The Company and each of its Subsidiaries maintain a system of internal accounting controls sufficient,
in the judgment of the Company’s board of directors, to provide reasonable assurance that (i) transactions are executed in
accordance with management’s general or specific authorizations, (ii) transactions are recorded as necessary to permit preparation
of financial statements in conformity with generally accepted accounting principles and to maintain asset accountability, (iii)
access to assets is permitted only in accordance with management’s general or specific authorization and (iv) the recorded
accountability for assets is compared with the existing assets at reasonable intervals and appropriate action is taken with respect
to any differences.

 

w.       Foreign
Corrupt Practices. Neither the Company, nor any of its Subsidiaries, nor any director, officer, agent, employee or other person
acting on behalf of the Company or any Subsidiary has, in the course of his actions for, or on behalf of, the Company, used any
corporate funds for any unlawful contribution, gift, entertainment or other unlawful expenses relating to political activity; made
any direct or indirect unlawful payment to any foreign or domestic government official or employee from corporate funds; violated
or is in violation of any provision of the U.S. Foreign Corrupt Practices Act of 1977, as amended, or made any bribe, rebate, payoff,
influence payment, kickback or other unlawful payment to any foreign or domestic government official or employee.

 

    	 	12	 

     

    

 

x.       Solvency.
The Company (after giving effect to the transactions contemplated by this Agreement) is solvent and currently the Company has no
information that would lead it to reasonably conclude that the Company would not, after giving effect to the transaction contemplated
by this Agreement, have the ability to, nor does it intend to take any action that would impair its ability to, pay its debts from
time to time incurred in connection therewith as such debts mature.

 

y.       No
Investment Company. The Company is not, and upon the issuance and sale of the Securities as contemplated by this Agreement
will not be an “investment company” required to be registered under the Investment Company Act of 1940 (an “Investment
Company”). The Company is not controlled by an Investment Company.

 

z.       Breach
of Representations and Warranties by the Company. If the Company breaches any of the representations or warranties set forth
in this Section 3, and in addition to any other remedies available to the Buyer pursuant to this Agreement, it will be considered
an Event of default under Section 3.4 of the Note.

 

4.       COVENANTS.

 

a.       Best
Efforts. The parties shall use their best efforts to satisfy timely each of the conditions described in Section 6 and 7 of
this Agreement.

 

b.       Form
D; Blue Sky Laws. The Company agrees to file a Form D with respect to the Securities as required under Regulation D and to
provide a copy thereof to the Buyer promptly after such filing. The Company shall, on or before the Closing Date, take such action
as the Company shall reasonably determine is necessary to qualify the Securities for sale to the Buyer at the applicable closing
pursuant to this Agreement under applicable securities or “blue sky” laws of the states of the United States (or to
obtain an exemption from such qualification), and shall provide evidence of any such action so taken to the Buyer on or prior to
the Closing Date.

 

c.       Use
of Proceeds. The Company shall use the proceeds for general working capital purposes.

 

d.       [INTENTIONALLY
DELETED] 

 

    	 	13	 

     

    

 

e.       Expenses.
At the Closing, the Company shall reimburse Buyer for expenses incurred by them in connection with the negotiation, preparation,
execution, delivery and performance of this Agreement and the other agreements to be executed in connection herewith (“Documents”),
including, without limitation, reasonable attorneys’ and consultants’ fees and expenses, transfer agent fees, fees
for stock quotation services, fees relating to any amendments or modifications of the Documents or any consents or waivers of provisions
in the Documents, fees for the preparation of opinions of counsel, escrow fees, and costs of restructuring the transactions contemplated
by the Documents. When possible, the Company must pay these fees directly, otherwise the Company must make immediate payment for
reimbursement to the Buyer for all fees and expenses immediately upon written notice by the Buyer or the submission of an invoice
by the Buyer. The Company’s obligation with respect to this transaction is to reimburse Buyer’ expenses shall be $3,500.00
for Buyer’s legal fees and due diligence fee.

 

f.       Financial
Information. Upon written request the Company agrees to send or make available the following reports to the Buyer until the
Buyer transfers, assigns, or sells all of the Securities: (i) within ten (10) days after the filing with the SEC, a copy of
its Annual Report on Form 10-K its Quarterly Reports on Form 10-Q and any Current Reports on Form 8-K; (ii) within one (1)
day after release, copies of all press releases issued by the Company or any of its Subsidiaries; and (iii) contemporaneously
with the making available or giving to the shareholders of the Company, copies of any notices or other information the Company
makes available or gives to such shareholders.

 

g.       [INTENTIONALLY
DELETED]

 

h.       Listing.
The Company shall promptly secure the listing of the Conversion Shares upon each national securities exchange or automated quotation
system, if any, upon which shares of Common Stock are then listed (subject to official notice of issuance) and, so long as the
Buyer owns any of the Securities, shall maintain, so long as any other shares of Common Stock shall be so listed, such listing
of all Conversion Shares from time to time issuable upon conversion of the Note. The Company will obtain and, so long as the Buyer
owns any of the Securities, maintain the listing and trading of its Common Stock on the OTCBB or any equivalent replacement exchange
or electronic quotation system (including but not limited to the Pink Sheets electronic quotation system) and will comply in all
respects with the Company’s reporting, filing and other obligations under the bylaws or rules of the Financial Industry Regulatory
Authority (“FINRA”) and such exchanges, as applicable. The Company shall promptly provide to the Buyer copies of any
notices it receives from the OTCBB and any other exchanges or electronic quotation systems on which the Common Stock is then traded
regarding the continued eligibility of the Common Stock for listing on such exchanges and quotation systems.

 

i.       Corporate
Existence. So long as the Buyer beneficially owns any Note, the Company shall maintain its corporate existence and shall not
sell all or substantially all of the Company’s assets, except in the event of a merger or consolidation or sale of all or
substantially all of the Company’s assets, where the surviving or successor entity in such transaction (i) assumes the Company’s
obligations hereunder and under the agreements and instruments entered into in connection herewith and (ii) is a publicly traded
corporation whose Common Stock is listed for trading on the Pink Sheets, OTCQX, OTCBB, Nasdaq, Nasdaq SmallCap, NYSE or AMEX.

 

    	 	14	 

     

    

 

j.       No
Integration. The Company shall not make any offers or sales of any security (other than the Securities) under circumstances
that would require registration of the Securities being offered or sold hereunder under the 1933 Act or cause the offering of the
Securities to be integrated with any other offering of securities by the Company for the purpose of any stockholder approval provision
applicable to the Company or its securities.

 

k.       Breach
of Covenants. If the Company breaches any of the covenants set forth in this Section 4, and in addition to any other remedies
available to the Buyer pursuant to this Agreement, it will be considered an event of default under Section 3.4 of the Note.

 

l.       Failure
to Comply with the 1934 Act. So long as the Buyer beneficially owns the Note, the Company shall comply with the reporting requirements
of the 1934 Act; and the Company shall continue to be subject to the reporting requirements of the 1934 Act.

 

m.       Trading
Activities. Neither the Buyer nor its affiliates has an open short position in the common stock of the Company and the Buyer
agree that it shall not, and that it will cause its affiliates not to, engage in any short sales of or hedging transactions with
respect to the common stock of the Company.

  

5.       Transfer
Agent Instructions. The Company shall issue irrevocable instructions to its transfer agent to issue certificates, registered
in the name of the Buyer or its nominee, for the Conversion Shares in such amounts as specified from time to time by the Buyer
to the Company upon conversion of the Note in accordance with the terms thereof (the “Irrevocable Transfer Agent Instructions”). 
In the event that the Borrower proposes to replace its transfer agent, the Borrower shall provide, prior to the effective date
of such replacement, a fully executed Irrevocable Transfer Agent Instructions in a form as initially delivered pursuant to the
Purchase Agreement (including but not limited to the provision to irrevocably reserve shares of Common Stock in the Reserved Amount)
signed by the successor transfer agent to Borrower and the Borrower. Prior to registration of the Conversion Shares under the 1933
Act or the date on which the Conversion Shares may be sold pursuant to Rule 144 without any restriction as to the number of Securities
as of a particular date that can then be immediately sold, all such certificates shall bear the restrictive legend specified in
Section 2(g) of this Agreement.  The Company warrants that: (i) no instruction other than the Irrevocable Transfer Agent Instructions
referred to in this Section 5, and stop transfer instructions to give effect to Section 2(f) hereof (in the case of the Conversion
Shares, prior to registration of the Conversion Shares under the 1933 Act or the date on which the Conversion Shares may be sold
pursuant to Rule 144 without any restriction as to the number of Securities as of a particular date that can then be immediately
sold), will be given by the Company to its transfer agent and that the Securities shall otherwise be freely transferable on the
books and records of the Company as and to the extent provided in this Agreement and the Note; (ii) it will not direct its transfer
agent not to transfer or delay, impair, and/or hinder its transfer agent in transferring (or issuing)(electronically or in certificated
form) any certificate for Conversion Shares to be issued to the Buyer upon conversion of or otherwise pursuant to the Note as and
when required by the Note and this Agreement; and (iii) it will not fail to remove (or directs its transfer agent not to remove
or impairs, delays, and/or hinders its transfer agent from removing) any restrictive legend (or to withdraw any stop transfer instructions
in respect thereof) on any certificate for any Conversion Shares issued to the Buyer upon conversion of or otherwise pursuant to
the Note as and when required by the Note and this Agreement.  Nothing in this Section shall affect in any way the Buyer’s
obligations and agreement set forth in Section 2(g) hereof to comply with all applicable prospectus delivery requirements, if any,
upon re-sale of the Securities.  If the Buyer provides the Company, at the cost of the Buyer, with (i) an opinion of counsel
in form, substance and scope customary for opinions in comparable transactions, to the effect that a public sale or transfer of
such Securities may be made without registration under the 1933 Act and such sale or transfer is effected or (ii) the Buyer provides
reasonable assurances that the Securities can be sold pursuant to Rule 144, the Company shall permit the transfer, and, in the
case of the Conversion Shares, promptly instruct its transfer agent to issue one or more certificates, free from restrictive legend,
in such name and in such denominations as specified by the Buyer.  The Company acknowledges that a breach by it of its obligations
hereunder will cause irreparable harm to the Buyer, by vitiating the intent and purpose of the transactions contemplated hereby. 
Accordingly, the Company acknowledges that the remedy at law for a breach of its obligations under this Section 5 may be inadequate
and agrees, in the event of a breach or threatened breach by the Company of the provisions of this Section, that the Buyer shall
be entitled, in addition to all other available remedies, to an injunction restraining any breach and requiring immediate transfer,
without the necessity of showing economic loss and without any bond or other security being required.

 

    	 	15	 

     

    

 

6.       Conditions
to the Company’s Obligation to Sell. The obligation of the Company hereunder to issue and sell the Note to the Buyer
at the Closing is subject to the satisfaction, at or before the Closing Date of each of the following conditions thereto, provided
that these conditions are for the Company’s sole benefit and may be waived by the Company at any time in its sole discretion:

 

a.       The
Buyer shall have executed this Agreement and delivered the same to the Company.

 

b.       The
Buyer shall have delivered the Purchase Price in accordance with Section 1(b) above.

 

c.       The
representations and warranties of the Buyer shall be true and correct in all material respects as of the date when made and as
of the Closing Date as though made at that time (except for representations and warranties that speak as of a specific date), and
the Buyer shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions required
by this Agreement to be performed, satisfied or complied with by the Buyer at or prior to the Closing Date.

 

d.       No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

7.       Conditions
to The Buyer’s Obligation to Purchase. The obligation of the Buyer hereunder to purchase the Note at the Closing is subject
to the satisfaction, at or before the Closing Date of each of the following conditions, provided that these conditions are for
the Buyer’s sole benefit and may be waived by the Buyer at any time in its sole discretion:

 

a.       The
Company shall have executed this Agreement and delivered the same to the Buyer.

 

b.       The
Company shall have delivered to the Buyer the duly executed Note (in such denominations as the Buyer shall request) in accordance
with Section 1(b) above.

 

c.       The
Irrevocable Transfer Agent Instructions, in form and substance satisfactory to a majority-in-interest of the Buyer, shall have
been delivered to and acknowledged in writing by the Company’s Transfer Agent.

 

d.       The
representations and warranties of the Company shall be true and correct in all material respects as of the date when made and as
of the Closing Date as though made at such time (except for representations and warranties that speak as of a specific date) and
the Company shall have performed, satisfied and complied in all material respects with the covenants, agreements and conditions
required by this Agreement to be performed, satisfied or complied with by the Company at or prior to the Closing Date. The Buyer
shall have received a certificate or certificates, executed by the chief executive officer of the Company, dated as of the Closing
Date, to the foregoing effect and as to such other matters as may be reasonably requested by the Buyer including, but not limited
to certificates with respect to the Company’s Certificate of Incorporation, By-laws and Board of Directors’ resolutions
relating to the transactions contemplated hereby.

 

e.       No
litigation, statute, rule, regulation, executive order, decree, ruling or injunction shall have been enacted, entered, promulgated
or endorsed by or in any court or governmental authority of competent jurisdiction or any self-regulatory organization having authority
over the matters contemplated hereby which prohibits the consummation of any of the transactions contemplated by this Agreement.

 

    	 	16	 

     

    

 

f.       No
event shall have occurred which could reasonably be expected to have a Material Adverse Effect on the Company including but not
limited to a change in the 1934 Act reporting status of the Company or the failure of the Company to be timely in its 1934 Act
reporting obligations.

 

g.       The
Conversion Shares shall have been authorized for quotation on the OTCBB and trading in the Common Stock on the OTCBB shall not
have been suspended by the SEC or the OTCBB.

 

h.       The
Buyer shall have received an officer’s certificate described in Section 3(c) above, dated as of the Closing Date.

 

8.       Governing
Law; Miscellaneous.

 

a.       Governing
Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Virginia without regard
to principles of conflicts of laws. Any action brought by either party against the other concerning the transactions contemplated
by this Agreement shall be brought only in the state courts of New York or in the federal courts located in the state and county
of Nassau. The parties to this Agreement hereby irrevocably waive any objection to jurisdiction and venue of any action instituted
hereunder and shall not assert any defense based on lack of jurisdiction or venue or based upon forum non conveniens. The
Company and Buyer waive trial by jury. The prevailing party shall be entitled to recover from the other party its reasonable attorney's
fees and costs. In the event that any provision of this Agreement or any other agreement delivered in connection herewith is invalid
or unenforceable under any applicable statute or rule of law, then such provision shall be deemed inoperative to the extent that
it may conflict therewith and shall be deemed modified to conform with such statute or rule of law. Any such provision which may
prove invalid or unenforceable under any law shall not affect the validity or enforceability of any other provision of any agreement.
Each party hereby irrevocably waives personal service of process and consents to process being served in any suit, action or proceeding
in connection with this Agreement or any other Transaction Document by mailing a copy thereof via registered or certified mail
or overnight delivery (with evidence of delivery) to such party at the address in effect for notices to it under this Agreement
and agrees that such service shall constitute good and sufficient service of process and notice thereof. Nothing contained herein
shall be deemed to limit in any way any right to serve process in any other manner permitted by law.

 

b.       Counterparts.
This Agreement may be executed in one or more counterparts, each of which shall be deemed an original but all of which shall constitute
one and the same agreement and shall become effective when counterparts have been signed by each party and delivered to the other
party.

 

    	 	17	 

     

    

 

c.       Headings.
The headings of this Agreement are for convenience of reference only and shall not form part of, or affect the interpretation of,
this Agreement.

 

d.       Severability.
In the event that any provision of this Agreement is invalid or unenforceable under any applicable statute or rule of law, then
such provision shall be deemed inoperative to the extent that it may conflict therewith and shall be deemed modified to conform
with such statute or rule of law. Any provision hereof which may prove invalid or unenforceable under any law shall not affect
the validity or enforceability of any other provision hereof.

 

e.       Entire
Agreement; Amendments. This Agreement and the instruments referenced herein contain the entire understanding of the parties
with respect to the matters covered herein and therein and, except as specifically set forth herein or therein, neither the Company
nor the Buyer makes any representation, warranty, covenant or undertaking with respect to such matters. No provision of this Agreement
may be waived or amended other than by an instrument in writing signed by the majority in interest of the Buyer.

 

f.       Notices.
All notices, demands, requests, consents, approvals, and other communications required or permitted hereunder shall be in writing
and, unless otherwise specified herein, shall be (i) personally served, (ii) deposited in the mail, registered or certified, return
receipt requested, postage prepaid, (iii) delivered by reputable air courier service with charges prepaid, or (iv) transmitted
by hand delivery, telegram, or facsimile, addressed as set forth below or to such other address as such party shall have specified
most recently by written notice. Any notice or other communication required or permitted to be given hereunder shall be deemed
effective (a) upon hand delivery or delivery by facsimile, with accurate confirmation generated by the transmitting facsimile machine,
at the address or number designated below (if delivered on a business day during normal business hours where such notice is to
be received), or the first business day following such delivery (if delivered other than on a business day during normal business
hours where such notice is to be received) or (b) on the second business day following the date of mailing by express courier service,
fully prepaid, addressed to such address, or upon actual receipt of such mailing, whichever shall first occur. The addresses for
such communications shall be:

 

If to the Company,
to:

GROW SOLUTIONS
HOLDINGS, INC.

1111 Broadway
- Suite 406

Denver, CO
80203

Attn: Jeffrey Beverly, President

Email:

 

    	 	18	 

     

    

 

With a copy
by fax only to (which copy shall not constitute notice):

 

If to the Buyer:

POWER UP LENDING GROUP
LTD.

111 Great Neck
Road, Suite 216

Great Neck,
NY 11021

Attn: Curt Kramer, Chief
Executive Officer

e-mail: info@poweruplending.com

 

With a copy
by fax only to (which copy shall not constitute notice):

Naidich Wurman LLP

111 Great Neck Road,
Suite 214

Great Neck, NY 11021

Attn: Allison Naidich

facsimile:
516-466-3555

e-mail: allison@nwlaw.com

 

Each party shall provide
notice to the other party of any change in address.

 

g.       Successors
and Assigns. This Agreement shall be binding upon and inure to the benefit of the parties and their successors and assigns.
Neither the Company nor the Buyer shall assign this Agreement or any rights or obligations hereunder without the prior written
consent of the other. Notwithstanding the foregoing, subject to Section 2(f), the Buyer may assign its rights hereunder to
any person that purchases Securities in a private transaction from the Buyer or to any of its “affiliates,” as that
term is defined under the 1934 Act, without the consent of the Company.

 

h.       Third
Party Beneficiaries. This Agreement is intended for the benefit of the parties hereto and their respective permitted successors
and assigns, and is not for the benefit of, nor may any provision hereof be enforced by, any other person.

 

i.       Survival.
The representations and warranties of the Company and the agreements and covenants set forth in this Agreement shall survive the
closing hereunder notwithstanding any due diligence investigation conducted by or on behalf of the Buyer. The Company agrees to
indemnify and hold harmless the Buyer and all their officers, directors, employees and agents for loss or damage arising as a result
of or related to any breach or alleged breach by the Company of any of its representations, warranties and covenants set forth
in this Agreement or any of its covenants and obligations under this Agreement, including advancement of expenses as they are incurred.

 

    	 	19	 

     

    

 

j.       Publicity.
The Company, and the Buyer shall have the right to review a reasonable period of time before issuance of any press releases, SEC,
OTCBB or FINRA filings, or any other public statements with respect to the transactions contemplated hereby; provided, however,
that the Company shall be entitled, without the prior approval of the Buyer, to make any press release or SEC, OTCBB (or other
applicable trading market) or FINRA filings with respect to such transactions as is required by applicable law and regulations
(although the Buyer shall be consulted by the Company in connection with any such press release prior to its release and shall
be provided with a copy thereof and be given an opportunity to comment thereon).

 

k.       Further
Assurances. Each party shall do and perform, or cause to be done and performed, all such further acts and things, and shall
execute and deliver all such other agreements, certificates, instruments and documents, as the other party may reasonably request
in order to carry out the intent and accomplish the purposes of this Agreement and the consummation of the transactions contemplated
hereby.

 

l.       No
Strict Construction. The language used in this Agreement will be deemed to be the language chosen by the parties to express
their mutual intent, and no rules of strict construction will be applied against any party.

 

m.       Remedies.
The Company acknowledges that a breach by it of its obligations hereunder will cause irreparable harm to the Buyer by vitiating
the intent and purpose of the transaction contemplated hereby. Accordingly, the Company acknowledges that the remedy at law for
a breach of its obligations under this Agreement will be inadequate and agrees, in the event of a breach or threatened breach by
the Company of the provisions of this Agreement, that the Buyer shall be entitled, in addition to all other available remedies
at law or in equity, and in addition to the penalties assessable herein, to an injunction or injunctions restraining, preventing
or curing any breach of this Agreement and to enforce specifically the terms and provisions hereof, without the necessity of showing
economic loss and without any bond or other security being required.

 

    	 	20	 

     

    

 

IN WITNESS WHEREOF,
the undersigned Buyer and the Company have caused this Agreement to be duly executed as of the date first above written.

 

GROW SOLUTIONS HOLDINGS, INC.

 

	By:		 
	 	Jeffrey Beverly	 
	 	President	 

 

POWER UP LENDING GROUP LTD.

 

	By: 		 
	Name:	 Curt Kramer	 
	Title: 	Chief Executive Officer	 

111 Great Neck Road, Suite 216

Great Neck, NY 11021

 

AGGREGATE SUBSCRIPTION AMOUNT:

 

	Aggregate Principal Amount of Note:	 	 	125,000.00	 
	 	 	 	 	 
	Aggregate Purchase Price:	 	 	125,000.00	 

 

 

21

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00273-of-00352.parquet"}]]